Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Erin Harvey to Humans

This is a "connection" page, showing publications Erin Harvey has written about Humans.

 
Connection Strength
  
 
 
0.159
  
  1. Harvey ES, Hamada Y, Hiles SA, Langton D, Thomas D, McDonald VM, Bardin P, Peters M, Reynolds PN, Upham JW, Blakey J, Bowler S, Chien J, Chung LP, Farah CS, Gillman A, Harrington J, Hew M, Jenkins C, Katelaris CH, Katsoulotos GP, Kritikos V, Lee J, Radhakrishna N, Sivakumaran P, Wark PAB, Gibson PG. Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab Registry. Respir Med. 2025 Nov; 248:108340.
    View in: PubMed
    Score: 0.024
  2. Harvey ES, Peters MJ. Asthma registries: Tedious paperwork or a versatile tool for the generation of knowledge-Insights from the Australasian Severe Asthma Registry (ASAR). Respirology. 2023 11; 28(11):986-988.
    View in: PubMed
    Score: 0.021
  3. Harvey ES, Langton D, Katelaris C, Stevens S, Farah CS, Gillman A, Harrington J, Hew M, Kritikos V, Radhakrishna N, Bardin P, Peters M, Reynolds PN, Upham JW, Baraket M, Bowler S, Bowden J, Chien J, Chung LP, Grainge C, Jenkins C, Katsoulotos GP, Lee J, McDonald VM, Reddel HK, Rimmer J, Wark PAB, Gibson PG. Mepolizumab effectiveness and identification of super-responders in severe asthma. Eur Respir J. 2020 05; 55(5).
    View in: PubMed
    Score: 0.017
  4. Hamada Y, Thomas D, McDonald VM, Harvey ES, Fricker M, Gillman A, Hew M, Kritikos V, Upham JW, Gibson PG. Impact of clinical remission on quality of life in severe eosinophilic asthma treated with mepolizumab. Ann Allergy Asthma Immunol. 2025 Nov; 135(5):537-546.e12.
    View in: PubMed
    Score: 0.006
  5. Thomas D, Lewthwaite H, Gibson PG, Majellano E, Clark V, Fricker M, Hamada Y, Anderson GP, Backer V, Bardin P, Beasley R, Chien J, Farah CS, Harrington J, Harvey E, Hew M, Holland AE, Jenkins C, Katelaris CH, Katsoulotos G, Murray K, Peters M, Thomas R, Tonga K, Upham JW, Wark P, McDonald VM. Unlocking Asthma Remission: Key Insights From an Expert Roundtable Discussion. Respirology. 2025 Jun; 30(6):466-479.
    View in: PubMed
    Score: 0.006
  6. Hamada Y, Thomas D, Harvey ES, Stevens S, Fricker M, Lewthwaite H, McDonald VM, Gillman A, Hew M, Kritikos V, Upham JW, Gibson PG. Distinct trajectories of treatment response to mepolizumab toward remission in patients with severe eosinophilic asthma. Eur Respir J. 2025 Jan; 65(1).
    View in: PubMed
    Score: 0.006
  7. Marinelli JP, Rahne T, Dornhoffer JR, Lohse CM, Cottrell J, Thomas Roland J, Thompson NJ, Brown KD, Lucas JC, Babu SC, Lindquist NR, Perkins EL, Tan D, Lane JI, Hunter JB, Harvey E, Deep NL, Cerasiello SY, Kircher ML, Espahbodi M, Tooker EL, West NC, Caye-Thomasen P, Carlson ML, Plontke SK. Cochlear Implantation With Sporadic Inner Ear Schwannomas: Outcomes in 106 Patients From an International Multi-Institutional Study. Otol Neurotol. 2025 Jan 01; 46(1):10-18.
    View in: PubMed
    Score: 0.006
  8. Chang WS, Harvey E, Mahar JE, Firth C, Shi M, Simon-Loriere E, Geoghegan JL, Wille M. Improving the reporting of metagenomic virome-scale data. Commun Biol. 2024 Dec 20; 7(1):1687.
    View in: PubMed
    Score: 0.006
  9. Dornhoffer JR, Marinelli JP, Lohse CM, Cottrell J, McMenomey SO, Roland JT, Thompson NJ, Brown KD, Lucas JC, Babu SC, Lindquist NR, Perkins EL, Rahne T, Plontke SK, Tan D, Hunter JB, Harvey E, Deep NL, Cerasiello SY, Kircher ML, Espahbodi M, Tooker EL, Lloyd SKW, Carlson ML. Comparing Cochlear Implant Outcomes in 100 Patients With Sporadic Vestibular Schwannoma Managed With Observation, Radiosurgery, or Microsurgery: A Multi-Institutional Review. Otol Neurotol. 2024 Dec 01; 45(10):e719-e726.
    View in: PubMed
    Score: 0.006
  10. Hamada Y, Gibson PG, Harvey ES, Stevens S, Lewthwaite H, Fricker M, McDonald VM, Gillman A, Hew M, Kritikos V, Upham JW, Thomas D. Early Treatment Response to Mepolizumab Predicts Clinical Remission in Severe Eosinophilic Asthma. J Allergy Clin Immunol Pract. 2025 Feb; 13(2):333-342.e9.
    View in: PubMed
    Score: 0.006
  11. Sadiq S, Harvey E, Mifsud JCO, Minasny B, McBratney AB, Pozza LE, Mahar JE, Holmes EC. Australian terrestrial environments harbour extensive RNA virus diversity. Virology. 2024 05; 593:110007.
    View in: PubMed
    Score: 0.005
  12. Thomas D, McDonald VM, Stevens S, Harvey ES, Baraket M, Bardin P, Bowden JJ, Bowler S, Chien J, Chung LP, Gillman A, Hew M, Hodge S, James A, Jenkins C, Katelaris CH, Katsoulotos GP, Langton D, Lee J, Marks G, Peters M, Radhakrishna N, Reynolds PN, Rimmer J, Sivakumaran P, Upham JW, Wark P, Yang IA, Gibson PG. Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients. Allergy. 2024 02; 79(2):384-392.
    View in: PubMed
    Score: 0.005
  13. Vertigan AE, Harvey ES, Beyene T, Van Buskirk J, Holliday EG, Bone SL, McDonald VM, Horvat JC, Murphy VE, Jensen ME, Morgan GG, Zosky GR, Peters M, Farah CS, Jenkins CR, Katelaris CH, Harrington J, Langton D, Bardin P, Katsoulotos GP, Upham JW, Chien J, Bowden JJ, Rimmer J, Bell R, Gibson PG. Impact of Landscape Fire Smoke Exposure on Patients With Asthma With or Without Laryngeal Hypersensitivity. J Allergy Clin Immunol Pract. 2023 10; 11(10):3107-3115.e2.
    View in: PubMed
    Score: 0.005
  14. Flanary V, Jefferson GD, Brown DJ, Arosarena OA, Brenner MJ, Cabrera-Muffly C, Cannon TY, Faucett EA, Francis CL, Harvey E, Johnson RF, Loyo M, Nance MA, Vinson KN, Thompson DM. Leadership of Black Women Faculty in Otolaryngology-More than A Rounding Error. Laryngoscope. 2023 05; 133(5):E36-E37.
    View in: PubMed
    Score: 0.005
  15. Kritikos V, Harvey ES, Stevens S, Katelaris CH, Langton D, Rimmer J, Farah CS, Gillman A, Hew M, Radhakrishna N, Thomas D, Gibson PG. Comorbidities Modify the Phenotype but Not the Treatment Effectiveness to Mepolizumab in Severe Eosinophilic Asthma. J Allergy Clin Immunol Pract. 2023 03; 11(3):885-895.e13.
    View in: PubMed
    Score: 0.005
  16. Beyene T, Harvey ES, Van Buskirk J, McDonald VM, Jensen ME, Horvat JC, Morgan GG, Zosky GR, Jegasothy E, Hanigan I, Murphy VE, Holliday EG, Vertigan AE, Peters M, Farah CS, Jenkins CR, Katelaris CH, Harrington J, Langton D, Bardin P, Katsoulotos GP, Upham JW, Chien J, Bowden JJ, Rimmer J, Bell R, Gibson PG. 'Breathing Fire': Impact of Prolonged Bushfire Smoke Exposure in People with Severe Asthma. Int J Environ Res Public Health. 2022 06 16; 19(12).
    View in: PubMed
    Score: 0.005
  17. Thomas D, Harvey ES, McDonald VM, Stevens S, Upham JW, Katelaris CH, Kritikos V, Gillman A, Harrington J, Hew M, Bardin P, Peters M, Reynolds PN, Langton D, Baraket M, Bowden JJ, Bowler S, Chien J, Chung LP, Farah CS, Grainge C, Jenkins C, Katsoulotos GP, Lee J, Radhakrishna N, Reddel HK, Rimmer J, Sivakumaran P, Wark PAB, Gibson PG. Mepolizumab and Oral Corticosteroid Stewardship: Data from the Australian Mepolizumab Registry. J Allergy Clin Immunol Pract. 2021 07; 9(7):2715-2724.e5.
    View in: PubMed
    Score: 0.004
  18. Wille M, Harvey E, Shi M, Gonzalez-Acuña D, Holmes EC, Hurt AC. Sustained RNA virome diversity in Antarctic penguins and their ticks. ISME J. 2020 07; 14(7):1768-1782.
    View in: PubMed
    Score: 0.004
  19. Wang E, Wechsler ME, Tran TN, Heaney LG, Jones RC, Menzies-Gow AN, Busby J, Jackson DJ, Pfeffer PE, Rhee CK, Cho YS, Canonica GW, Heffler E, Gibson PG, Hew M, Peters M, Harvey ES, Alacqua M, Zangrilli J, Bulathsinhala L, Carter VA, Chaudhry I, Eleangovan N, Hosseini N, Murray RB, Price DB. Characterization of Severe Asthma Worldwide: Data From the International Severe Asthma Registry. Chest. 2020 04; 157(4):790-804.
    View in: PubMed
    Score: 0.004
  20. Denton E, Hore-Lacy F, Radhakrishna N, Gilbert A, Tay T, Lee J, Dabscheck E, Harvey ES, Bulathsinhala L, Fingleton J, Price D, Gibson PG, O'Hehir R, Hew M. Severe Asthma Global Evaluation (SAGE): An Electronic Platform for Severe Asthma. J Allergy Clin Immunol Pract. 2019 May - Jun; 7(5):1440-1449.
    View in: PubMed
    Score: 0.004
  21. McDonald VM, Hiles SA, Godbout K, Harvey ES, Marks GB, Hew M, Peters M, Bardin PG, Reynolds PN, Upham JW, Baraket M, Bhikoo Z, Bowden J, Brockway B, Chung LP, Cochrane B, Foxley G, Garrett J, Jayaram L, Jenkins C, Katelaris C, Katsoulotos G, Koh MS, Kritikos V, Lambert M, Langton D, Lara Rivero A, Middleton PG, Nanguzgambo A, Radhakrishna N, Reddel H, Rimmer J, Southcott AM, Sutherland M, Thien F, Wark PAB, Yang IA, Yap E, Gibson PG. Treatable traits can be identified in a severe asthma registry and predict future exacerbations. Respirology. 2019 01; 24(1):37-47.
    View in: PubMed
    Score: 0.004
  22. Bulathsinhala L, Eleangovan N, Heaney LG, Menzies-Gow A, Gibson PG, Peters M, Hew M, van Boven JFM, Lehtimäki L, van Ganse E, Belhassen M, Harvey ES, Perez de Llano L, Maitland-van der Zee AH, Papadopoulos NG, FitzGerald JM, Porsbjerg C, Canonica GW, Backer V, Rhee CK, Verhamme KMC, Buhl R, Cosio BG, Carter V, Price C, Le T, Stagno d'Alcontres M, Gopalan G, Tran TN, Price D. Development of the International Severe Asthma Registry (ISAR): A Modified Delphi Study. J Allergy Clin Immunol Pract. 2019 02; 7(2):578-588.e2.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)